Esperance Pharmaceuticals, Inc.
PrivateCompany Overview
Esperance Pharmaceuticals, Inc. is a biotechnology company that develops targeted anti-cancer drugs using its proprietary cationic lytic peptide (CLYP) technology platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biotechnologyanticancer drugstargeted therapypeptide therapeuticscationic lytic peptideCLYPantibody-drug conjugatesADConcologydrug discoveryprecision medicineclinical trialsbiotech startupcancer researchdrug development
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Esperance Pharmaceuticals, Inc. Comparables
Compare Esperance Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| A28 Therapeutics | 88% | |
| Cybrexa Therapeutics | 79% | |
| Oncolyze, Inc. | 77% | |
Esperance Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
Esperance Pharmaceuticals, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Esperance Pharmaceuticals, Inc.'s valuation, stock price, and market status.
See something wrong or outdated?